These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3454763)

  • 21. Antigenic and cellular heterogeneity of primary uveal melanomas.
    Folberg R
    Arch Ophthalmol; 1986 Jun; 104(6):795, 798-9. PubMed ID: 3487304
    [No Abstract]   [Full Text] [Related]  

  • 22. Detection of malignant melanoma with monoclonal antibodies.
    Saxton RE; Burke MW; Torbett B; Fairhurst M; Morton DL; Cochran AJ
    Dis Markers; 1988 Jun; 6(2):97-108. PubMed ID: 3042264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human-human hybridomas and human monoclonal antibodies obtained by fusion of lymph node lymphocytes from breast cancer patients.
    Kjeldsen TB; Rasmussen BB; Rose C; Zeuthen J
    Cancer Res; 1988 Jun; 48(11):3208-14. PubMed ID: 3365703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A monoclonal antibody specific for cells of the melanocyte lineage.
    Vennegoor C; Hageman P; Van Nouhuijs H; Ruiter DJ; Calafat J; Ringens PJ; Rümke P
    Am J Pathol; 1988 Jan; 130(1):179-92. PubMed ID: 3276209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antiidiotypic antibodies related to the p97 human melanoma antigen.
    Kahn M; Hellström I; Estin CD; Hellström KE
    Cancer Res; 1989 Jun; 49(12):3157-62. PubMed ID: 2470502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunophenotypic markers to differentiate between benign and malignant melanocytic lesions.
    Keijser S; Missotten GS; Bonfrer JM; de Wolff-Rouendaal D; Jager MJ; de Keizer RJ
    Br J Ophthalmol; 2006 Feb; 90(2):213-7. PubMed ID: 16424536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence of macrophage and lymphocyte, but not dendritic cell, infiltration in posterior uveal melanomas, whilst cultured uveal melanomas demonstrate pluripotency by expressing CD68 and CD163.
    Woodward J; Sisley K; Reeves G; Nichols C; Parsons MA; Mudhar H; Rennie I
    Int J Exp Pathol; 2004 Feb; 85(1):35-43. PubMed ID: 15113392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro targeting of NG2 antigen by 213Bi-9.2.27 alpha-immunoconjugate induces cytotoxicity in human uveal melanoma cells.
    Li Y; Wang J; Rizvi SM; Jager MJ; Conway RM; Billson FA; Allen BJ; Madigan MC
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4365-71. PubMed ID: 16303921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigen expression in canine tissues, recognized by a monoclonal antibody generated against canine melanoma cells.
    Oliver JL; Wolfe LG
    Am J Vet Res; 1992 Jan; 53(1):123-8. PubMed ID: 1539903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presence and phenotype of dendritic cells in uveal melanoma.
    Polak ME; Borthwick NJ; Johnson P; Hungerford JL; Higgins B; Di Palma S; Jager MJ; Cree IA
    Br J Ophthalmol; 2007 Jul; 91(7):971-6. PubMed ID: 17347328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum antibodies against feline oncornavirus-associated cell membrane antigen in cats bearing virally induced uveal melanomas.
    Niederkorn JY; Shadduck JA; Albert D; Essex M
    Invest Ophthalmol Vis Sci; 1981 May; 20(5):598-605. PubMed ID: 6260702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous cellular and humoral tumor antigen responses in patients with uveal melanoma.
    Triozzi PL; Aldrich W; Crabb JW; Singh AD
    Melanoma Res; 2015 Dec; 25(6):510-8. PubMed ID: 26397048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-reactivity of murine anti-human high molecular weight-melanoma associated antigen monoclonal antibodies with guinea pig melanoma cells.
    Liao SK; Smith JW; Kwong PC; Natali PG; Kusama M; Hamby CV; Ferrone S
    Cancer Res; 1987 Sep; 47(18):4835-41. PubMed ID: 3476198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.
    Blom DJ; Luyten GP; Mooy C; Kerkvliet S; Zwinderman AH; Jager MJ
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1865-72. PubMed ID: 9286277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Reaction of leukocyte migration inhibition in patients with uveal melanoblastoma].
    Nifontova TP
    Vopr Onkol; 1986; 32(4):57-61. PubMed ID: 3705529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoassay for melanoma-associated proteoglycan in the sera of patients using monoclonal and polyclonal antibodies.
    Ross AH; Herlyn M; Ernst CS; Guerry D; Bennicelli J; Ghrist BF; Atkinson B; Koprowski H
    Cancer Res; 1984 Oct; 44(10):4642-7. PubMed ID: 6380710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GPNMB expression in uveal melanoma: a potential for targeted therapy.
    Williams MD; Esmaeli B; Soheili A; Simantov R; Gombos DS; Bedikian AY; Hwu P
    Melanoma Res; 2010 Jun; 20(3):184-90. PubMed ID: 20375921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific immunoreactivity of hybridoma-secreted monoclonal anti-melanoma antibodies to cultured cells and freshly derived human cells.
    Herlyn M; Clark WH; Mastrangelo MJ; Guerry DP; Elder DE; LaRossa D; Hamilton R; Bondi E; Tuthill R; Steplewski Z; Koprowski H
    Cancer Res; 1980 Oct; 40(10):3602-9. PubMed ID: 6159966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA expression in a primary uveal melanoma, its cell line, and four of its metastases.
    Blom DJ; Schurmans LR; De Waard-Siebinga I; De Wolff-Rouendaal D; Keunen JE; Jager MJ
    Br J Ophthalmol; 1997 Nov; 81(11):989-93. PubMed ID: 9505825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.